TheraRadar
← Back
Data updated: Mar 29, 2026

WARNER CHILCOTT LLC

CardiovascularNeurologyGastroenterology
Specialty

WARNER CHILCOTT LLC is a specialty pharmaceutical company focused on Cardiovascular, Neurology, Gastroenterology.

1949
Since
43
Drugs
-
Trials
260
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
PROPRANOLOL HYDROCHLORIDE 2026-01-27
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 43%
3 drugs
Neurology 29%
2 drugs
Gastroenterology 14%
1 drugs
Infectious Disease 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease, Neurology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Novo Nordisk big-pharma
Cardiovascular, Infectious Disease, Neurology
Pfizer big-pharma
Infectious Disease, Gastroenterology